September 15, 2023
Xarelto Bleeding – The Trials Go On
- Last Updated: August 4th, 2023
Xarelto Bleeding – The Trials Go On
Despite a last ditch effort by the defendants to avoid another trip to court, Dora Mingo, who experienced a serious Xarelto bleeding event, will see her day in court.
The Honorable Eldon E. Fallon, Eastern District of Louisiana, ruled in favor of the plaintiffs last week denying a request for partial summary judgment by Janssen (a unit of Johnson & Johnson) and Bayer HealthCare Pharmaceuticals Inc.
Dora Mingo developed deep vein thrombosis (DVT) after having her hip replaced in 2015.
She was given Xarelto to treat the DVT.
Like many other individuals harmed by Xarelto, Mingo experienced uncontrollable bleeding that required hospitalization.
Mingo’s lawsuit alleges that Janssen and Bayer knew of the Xarelto bleeding events likelihood and did not warn patients or doctors.
There are more than 18,000 Xarelto bleeding lawsuits centralized in federal multidistrict litigation under the care of Judge Fallon in Lousiana.
Mingo’s case is serving as the third bellwether trial, selected by the court to be fully prepared and tried by a jury.
Mingo’s case is designed to help move along possible settlements for other individuals injured by Xarelto in order to avoid clogging the courts with 18,000 cases with similar facts – use of a common product, Xarelto, and common defendant, Janssen and Bayer.
Mingo is the third plaintiff to go to trial.
The two prior bellwether trials returned verdicts in favor of the defendants.
Partial summary judgment is a procedural device that is used during civil litigation to promptly dispose of an entire case without a trial.
It can be used either on the merits of the case or on discrete issues in the case.
By rejecting the request for partial summary judgment, Judge Fallon is indicating that Mingo’s case has legal merit and decision on whether Xarelto caused her DVT will be left to a jury.
We look forward to keeping TruLaw followers and clients updated as to the result of the third Xarelto bellwether case.
Table of Contents
Written By:
Jessie Paluch
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Do You
Have A Case?
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
About TruLaw
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
Camp Lejeune Lawsuit
Tylenol Lawsuit
AFFF Lawsuit
Camp Lejeune Lawsuit
Camp Lejeune Lawsuit
Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.
Tylenol Lawsuit
Tylenol Lawsuit
Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.
AFFF Lawsuit
AFFF Lawsuit
Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.
Recent Posts
Do You
Have A Case?
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
Related Articles
FDA warns – Weis Quality Brownie Moose Tracks Ice Cream, 48oz recalled due to undeclared egg
Weis Market Inc., a Mid-Atlantic food retailer based in Sunbury, Pennsylvania, has recalled its 48-ounce containers of Weis Quality Brownie Moose Tracks Ice Cream because the product may contain traces of egg, an allergen not declared on the ingredient statement label, according to the FDA.
September 15, 2023
FDA warns – Single lot of Digoxin Tablets USP in 0.125mg, 0.25mg recalled due to swapped labels
Marlex Pharmaceuticals, Inc., of New Castle, Delaware, has announced a voluntary, consumer-level recall of one lot of Digoxin Tablets USP, 0125mg, as well as one lot of Digoxin Tablets USP, 0.25mg, because the labels of both products have been mixed up, according to the FDA.
September 14, 2023